152 related articles for article (PubMed ID: 38892471)
1. Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application?
Asante DB; Tierno D; Woode M; Scaggiante B
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892471
[TBL] [Abstract][Full Text] [Related]
2. Circulating endothelial and endothelial progenitor cells in non-small-cell lung cancer.
Fleitas T; Martínez-Sales V; Gómez-Codina J; Martín M; Reynés G
Clin Transl Oncol; 2010 Aug; 12(8):521-5. PubMed ID: 20709649
[TBL] [Abstract][Full Text] [Related]
3. PD-L1
Zhang L; Zhang X; Liu Y; Zhang T; Wang Z; Gu M; Li Y; Wang DD; Li W; Lin PP
Cancer Lett; 2020 Jan; 469():355-366. PubMed ID: 31678168
[TBL] [Abstract][Full Text] [Related]
4. Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis.
Flamini V; Jiang WG; Lane J; Cui YX
Crit Rev Oncol Hematol; 2016 Apr; 100():177-89. PubMed ID: 26917455
[TBL] [Abstract][Full Text] [Related]
5. Circulating endothelial progenitor cell: a promising biomarker in clinical oncology.
Ge YZ; Wu R; Lu TZ; Xin H; Yu P; Zhao Y; Liu H; Xu Z; Xu LW; Shen JW; Xu X; Zhou LH; Li WC; Zhu JG; Jia RP
Med Oncol; 2015 Jan; 32(1):332. PubMed ID: 25428376
[TBL] [Abstract][Full Text] [Related]
6. Aneuploid Circulating Tumor-Derived Endothelial Cell (CTEC): A Novel Versatile Player in Tumor Neovascularization and Cancer Metastasis.
Lin PP
Cells; 2020 Jun; 9(6):. PubMed ID: 32599893
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis in epithelian ovarian cancer.
Bamberger ES; Perrett CW
Mol Pathol; 2002 Dec; 55(6):348-59. PubMed ID: 12456770
[TBL] [Abstract][Full Text] [Related]
8. Targeting the tumour microenvironment in ovarian cancer.
Hansen JM; Coleman RL; Sood AK
Eur J Cancer; 2016 Mar; 56():131-143. PubMed ID: 26849037
[TBL] [Abstract][Full Text] [Related]
9. Kynurenine in IDO1
Ying X; Zheng X; Zhang X; Yin Y; Wang X
J Transl Med; 2024 Mar; 22(1):267. PubMed ID: 38468343
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of circulating endothelial progenitor cells and related angiogenic markers as prognostic factors in soft-tissue tumors.
Karampinis I; Joas E; Dreyer A; Ronellenfitsch U; Jakob J; Hohenberger P; Nowak K
Eur J Surg Oncol; 2018 Apr; 44(4):496-501. PubMed ID: 29397265
[TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
Goon PK; Lip GY; Stonelake PS; Blann AD
Neoplasia; 2009 Aug; 11(8):771-9. PubMed ID: 19649207
[TBL] [Abstract][Full Text] [Related]
13. Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy.
Wong CK; Namdarian B; Chua J; Chin X; Speirs R; Nguyen T; Fankhauser M; Pedersen J; Costello AJ; Corcoran NM; Hovens CM
Br J Cancer; 2012 Oct; 107(9):1564-73. PubMed ID: 23047552
[TBL] [Abstract][Full Text] [Related]
14. Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy.
Mehran R; Nilsson M; Khajavi M; Du Z; Cascone T; Wu HK; Cortes A; Xu L; Zurita A; Schier R; Riedel B; El-Zein R; Heymach JV
Cancer Res; 2014 May; 74(10):2731-41. PubMed ID: 24626092
[TBL] [Abstract][Full Text] [Related]
15. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
Wang X; Li X; Wang X
J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171
[TBL] [Abstract][Full Text] [Related]
16. Circulating endothelial cells and their subpopulations: role as predictive biomarkers in antiangiogenic therapy for colorectal cancer.
Manzoni M; Comolli G; Torchio M; Mazzini G; Danova M
Clin Colorectal Cancer; 2015 Mar; 14(1):11-7. PubMed ID: 25591800
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer.
Gasparri ML; Savone D; Besharat RA; Farooqi AA; Bellati F; Ruscito I; Panici PB; Papadia A
Tumour Biol; 2016 Jan; 37(1):71-5. PubMed ID: 26500096
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy.
Dome B; Timar J; Ladanyi A; Paku S; Renyi-Vamos F; Klepetko W; Lang G; Dome P; Bogos K; Tovari J
Crit Rev Oncol Hematol; 2009 Feb; 69(2):108-24. PubMed ID: 18768327
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations following ionizing radiation in human ovarian cancer-derived endothelial cells.
Liu T; Du X; Sheng X
Mol Med Rep; 2014 Jun; 9(6):2257-64. PubMed ID: 24691555
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelial progenitor cells in malignant gliomas.
Rafat N; Beck GCh; Schulte J; Tuettenberg J; Vajkoczy P
J Neurosurg; 2010 Jan; 112(1):43-9. PubMed ID: 19522573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
